Thursday, August 25, 2016

BRIEF-Viking Therapeutics enters into $12.5 million common stock purchase agreement with Aspire Capital

* Viking Therapeutics enters into $12.5 million common stock

purchase agreement with Aspire Capital

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)